Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-21 6:41:57 pm | Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date | GlobeNewsWire |
| 2024-03-20 1:5:0 pm | Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device | GlobeNewswire |
| 2024-03-01 6:41:0 am | Myriad Genetics (MYGN) to Evaluate MRD Testing With New Pact | Zacks |
| 2024-02-29 6:50:11 am | Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio | Zacks |
| 2024-02-29 2:48:43 am | Myriad Genetics Full Year 2023 Earnings: EPS Misses Expectations | Simply Wall St. |
| 2024-02-28 8:24:20 am | Q4 2023 Myriad Genetics Inc Earnings Call | Thomson Reuters StreetEvents |
| 2024-02-28 7:24:53 am | Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript | Insider Monkey |
| 2024-02-28 4:50:0 am | Myriad Genetics (MYGN) Q4 Earnings Top Estimate, Margins Down | Zacks |
| 2024-02-27 4:0:7 pm | Myriad (MYGN) Reports Q4 Earnings: What Key Metrics Have to Say | Zacks |
Please consider a small donation if you think this website provides you with relevant information